Total revenue of $25.7 million, up 6% sequentially 4 licensing deals signed for NeuPro NPUs, marking pivotal moment for Ceva's AI business 2 strategic automotive IP agreements secured ...

Durability remains a top priority for customers. Today’s grand touring technology helps evenly distribute pressure across the ...

The end of the classic Control Panel is approaching. In the Windows Insider previews, Microsoft is now shifting more to the settings.

Tinlarebant granted Breakthrough Therapy Designation for Stargardt disease (STGD1) by the U.S. Food and Drug Administration (FDA)DRAGON trial completion expected by Q4 2025 (including a three-month fo ...